Ask AI
ProCE Banner Series

Conference to Clinic: Integrating CD38-Based Quadruplet Therapy Into Care of Transplant-Ineligible and Transplant-Eligible NDMM

Enhance your understanding of anti-CD38 antibody–based quadruplet regimens for the management of newly diagnosed multiple myeloma to improve the care of transplant-ineligible and transplant-eligible as well as underserved patients through a certified on-demand webcast and accompanying downloadable slides.

  AMA
Who Should Attend

This educational activity is intended for hematologists, medical oncologists, and other healthcare professionals who care for patients with multiple myeloma.

All Events

Conference to Clinic: Integrating CD38-Based Quadruplet Therapy Into Care of Transplant-Ineligible and Transplant-Eligible NDMM

Upcoming Events

July

16

2025

6:30 PM - 8:00 PM Eastern Time (ET)

Virtual

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge, confidence, and competence of learners in using anti-CD38 antibody–based quadruplet regimens to care for patients with multiple myeloma. 

Target Audience
This educational activity is intended for hematologists, medical oncologists, and other healthcare professionals who care for patients with multiple myeloma.  

Learning Objectives
Upon completion of this event, participants should be able to:

  • Identify patients with newly diagnosed MM who are most likely to benefit from anti-CD38 antibody-based quadruplet regimens
  • Develop individualized treatments leveraging anti-CD38 antibody-based quadruplet regimens for patients with newly diagnosed MM based on current recommendations, approvals, clinical data, and patient factors 
  • Plan supportive care approaches to mitigate the risk of treatment-related adverse events in patients with newly diagnosed MM initiating treatment with anti-CD38 antibody–based quadruplet regimens
  • Implement strategies supporting equitable access to novel therapies and supportive care in Black and underserved patients with MM

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification 

A blue and black sign with white textDescription automatically generated

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through CCO's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC.

CCO 2022

Supporters

Supported by an educational grant from Sanofi Genzyme.

Sanofi Genzyme

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191